Peptide Sequence Determination MS-MS
Peptide sequencing is a core aspect of proteomics research, involving the precise identification of the sequence of proteins or peptides. MS-MS, or Tandem Mass Spectrometry, is a powerful technique to achieve this goal. This article will introduce the basic principles of peptide sequencing, the working mechanism of MS-MS technology, and its applications in biomedical research.
1. Basic Principles
Sequencing of proteins or peptides is based on the identification of the constituent amino acids. Each protein is a long-chain molecule composed of 20 different amino acids arranged in a specific order, known as the protein sequence. Determining the sequence of a protein essentially involves identifying the order of these amino acids.
2. MS-MS Technology
Tandem mass spectrometry achieves peptide sequencing through two stages of mass spectrometry analysis. First, in the first stage (MS1), the mixed protein sample is ionized into charged molecules (ions) and then separated based on their mass-to-charge ratio (m/z). Next, specific ions are selected for further analysis in the second stage (MS2). In MS2, these selected ions are further broken down into smaller fragment ions. By analyzing the m/z of these fragment ions, the amino acid sequence of the original peptide can be deduced.
3. Procedural Workflow
1. Sample Preparation Protein Extraction: Extract proteins from biological samples and cleave them into peptides using enzymes such as trypsin. Peptide Purification: Use chromatographic techniques (such as liquid chromatography) to purify the cleaved peptides, reducing sample complexity and enhancing the sensitivity of subsequent analysis.
2. MS/MS Analysis First Stage Mass Spectrometry (MS1): The peptide sample is introduced into the mass spectrometer and ionized (commonly using Electrospray Ionization, ESI, or Matrix-Assisted Laser Desorption/Ionization, MALDI). The ionized peptide ions are measured for their m/z in the first stage mass spectrometry. Ion Selection and Fragmentation: Specific peptide ions are selected based on their m/z value and sent to a collision chamber, where they are fragmented. This process generates a series of fragment ions representing different parts of the original peptide sequence. Second Stage Mass Spectrometry (MS2): The m/z values of these fragment ions are measured in the second stage mass spectrometry, producing a spectrum, i.e., an MS/MS spectrum.
Figure 1. Protein/Peptide Tandem Mass Spectrometry Sequencing Workflow
4. Sequence Determination and Spectrum Analysis
The MS/MS spectrum is analyzed to identify the type and order of fragment ions, which is used to deduce the amino acid sequence of the original peptide. Database Search: Use specific software (such as Mascot, SEQUEST, or MaxQuant) to match MS/MS data with known protein databases to determine the peptide sequence.
MS-MS technology is a powerful tool essential for understanding the molecular mechanisms of biological systems. By accurately identifying the sequences of proteins and peptides, it helps scientists uncover the secrets of many life processes, advancing biomedical research. With technological advancements and expanded applications, MS-MS will continue to play an important role in proteomics and related fields.
BioTop-Biotech—Characterization of Bioproducts, High-Quality Mass Spectrometry Services for Multi-Omics
Related Services:
How to order?
